Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2009/04/01
-
Journal
-
Indian UGC (journal)
-
Refrences32
-
Citations113
-
Emmanouil Fokas
-
Ulrich Wacker
-
Markus W. Gross
-
Martin Henzel
-
Elitsa Encheva
-
Rita Engenhart-Cabillic
Cite
Fokas, Emmanouil, et al. “Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas”. Strahlentherapie Und Onkologie, vol. 185, no. 4, 2009, pp. 235-40, https://doi.org/10.1007/s00066-009-1753-x.
Fokas, E., Wacker, U., Gross, M. W., Henzel, M., Encheva, E., & Engenhart-Cabillic, R. (2009). Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas. Strahlentherapie Und Onkologie, 185(4), 235-240. https://doi.org/10.1007/s00066-009-1753-x
Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R. Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas. Strahlentherapie und Onkologie. 2009;185(4):235-40.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
Medicine
Medicine (General)
Medical physics
Medical radiology
Nuclear medicine
You May Also Like
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
- Thermal dose determination in cancer therapy
- Use of Normal Tissue Complication Probability Models in the Clinic
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
Refrences
Refrences Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 10
is the most frequently represented among the references in this article. It primarily includes studies from Journal of Neuro-Oncology and American Journal of Clinical Oncology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse | Journal of Neuro-Oncology |
| 2024 | |
| Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma | International Journal of Radiation Oncology*Biology*Physics |
| 2024 | |
| Promising outcome of patients with recurrent glioblastoma after Gamma Knife-based hypofractionated radiotherapy | Neurochirurgie |
| 2024 | |
The evolving role of reirradiation in the management of recurrent brain tumors | Journal of Neuro-Oncology |
| 2 | 2023 |
| Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis | Clinical Neurology and Neurosurgery |
| 1 | 2023 |
Citations Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 86
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Combined Cetuximab and Reirradiation for Locoregional Recurrent and Inoperable Squamous Cell Carcinoma of the Head and Neck and was published in 2009. The most recent citation comes from a 2024 study titled Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse. This article reached its peak citation in 2012, with 13 citations. It has been cited in 51 different journals, 21% of which are open access. Among related journals, the Strahlentherapie und Onkologie cited this research the most, with 22 citations. The chart below illustrates the annual citation trends for this article.